Further studies, especially randomized clinical trials, are required to confirm the efficacy and safety of QE as a potential treatment

The gap

Evidence profile

Sourced from the future work and future-work section of the source papers, classified as general, drawn from work published between 2025 and 2026, spanning 3 journals. Those papers have been cited 35 times in total.

Supporting evidence — 3 representative gaps

• Quercetin: An Emerging Natural Flavonoid in Modern Therapeutics with Multifaceted Pharmacological Potential (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi

  AND FUTURE This review highlights quercetin as a key dietary flavonoid with broad pharmacological potential, anti-inflammatory, including antioxidant, anticancer, antidiabetic, cardioprotective, antiviral, neuroprotective, anti-obesity, anti-arthritic, wound-healing, immunomodulatory, and other beneficial effects demonstrated in extensive in vitro and in vivo studies. These pleiotropic actions arise from its ability to INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES 4047 | P a g e Arushi Shukla, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 4035-4050 | Review should to therefore modulate multiple signaling pathways, enzymes, transcription factors, and non-coding RNAs, positioning quercetin as a promising multi-target candidate for the prevention and management of diverse chronic diseases. However, clinical evidence is still limited compared with the robust preclinical data, and its poor aqueous solubility, rapid metabolism, and low oral bioavailability translation. Future remain major barriers research (i) prioritize well-designed, adequately powered clinical trials in specific disease settings; (ii) detailed elucidation of pharmacokinetics, metabolism, and long-term safety in humans; and (iii) rational development of advanced as nanoformulations, lipid-based carriers, polymeric nanoparticles, inclusion complexes—to enhance stability, tissue targeting, and systemic exposure. In parallel, dietary strategies that emphasise quercetin-rich foods, evidence-based standardized, together with nutraceutical support a formulations, may preventive, integrative approach to health. Overall, with continued interdisciplinary efforts, quercetin has the potential to move from a widely consumed nutraceutical to a clinically validated adjunct or lead compound in modern pharmacotherapy. systems—such micelles, delivery and REFERENCES 1. Abdulkarim, M. F., Abdullah, G. Z., Chitneni, M., Salman, I. M., Ameer, O. Z., Yam, M. F., et al. (2010). Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream. of

  generalfuture workevidence 5/5
  Keywords: quercetin anti based future review dietary potential inflammatory effects vitro vivo clinical evidence metabolism nutraceutical
• Quercetin as a therapeutic agent for acute pancreatitis: a comprehensive review of antioxidant, anti-inflammatory, and immunomodulatory mechanisms (2025) · Frontiers in Pharmacology · cited 16× · doi

  Quercetin holds significant promise as a multi-target therapeutic in AP, thanks to its antioxidant, anti-inflammatory, and immune- its clinical modulatory properties (Sun et al., 2025). However, application is limited by poor bioavailability, which affects its efficacy, particularly in severe conditions like AP. Nanoparticles and liposomal formulations have shown potential to improve its bioavailability, but these approaches need extensive validation to assess long-term safety and clinical relevance. While preclinical models show positive results, there is a critical gap in data regarding optimal dosing, side effects, and drug interactions with agents like NAC and corticosteroids (Dhanya, 2022); Xing et al., 2024. This warrants caution, as combining quercetin with these therapies could either enhance or undermine their therapeutic effects.Beyond AP, quercetin’s fibrosis-reducing and tissue- healing effects suggest that it may also hold promise for treating chronic pancreatitis and other pancreatic disorders (Georgiou et al., 2023). However, trials in chronic the lack of robust clinical conditions and comorbid patients highlights the need for more targeted research. action on inflammation and fibrosis may offer advantages over existing treatments but also raises concerns about the balance between its anti-inflammatory and potential immunosuppressive effects.Future studies should focus not only on optimizing formulations but also on exploring quercetin’s long-term safety in real-world conditions, especially in combination therapies. Addressing these clinical gaps will be key to unlocking quercetin’s full potential as a therapeutic agent for acute and chronic pancreatic diseases. Importantly, quercetin’s dual In summary, quercetin’s ability to target multiple pathological mechanisms, including oxidative stress, inflammation, and immune dysregulation, makes it a promising candidate for the treatment of AP. Its unique multi-target profile offers distinct advantages over single-target therapies. Although current preclinical data are promising, further clinical validation is essential to establish its efficacy and safety. With continued research and clinical trials, quercetin has the potential to transform the management of pancreatitis and related inflammatory disorders, advancing from the preclinical stage to widespread therapeutic use.

  generalfuture workevidence 5/5
  Keywords: quercetin clinical target therapeutic potential effects ammatory conditions safety preclinical therapies chronic promise multi anti
• Potential of Quercetin as a Promising Therapeutic Agent Against Type 2 Diabetes (2025) · Molecules · cited 19× · doi

  further studies, especially randomized clinical trials, are required to confirm the efficacy and safety of QE as a potential treatment for the facilitation of insulin secretion and enhancement in insulin sensitivity in humans - further research is required in both basic and clinical contexts to enable a more comprehensive evaluation of the potential of quercetin as a therapeutic agent in the treatment and prevention of retinopathy, nephropathy, neuropathy, and other complications resulting from chronic hyperglycemia - analysis of the potential role of QE in regulating iron metabolism in the context of diabetes

  generalfuture-work sectionevidence 5/5
  Keywords: further studies especially randomized clinical trials required confirm

Questions about this gap